- Evaluation of Immunogenicity and Safety of the New Tetanus-Reduced Diphtheria (Td) Vaccines (GC1107) in Healthy Korean Adolescents: A Phase II, Double-Blind, Randomized, Multicenter Clinical Trial
-
Rhim JW, Lee KY, Kim SY, Kim JH, Kim HH, Kim HM, Choi YY, Ma SH, Kim DH, Ahn DH, Kang JH
- KMID: 1786968
- J Korean Med Sci.
- 2013 Apr;28(4):586-592.
- doi: 10.3346/jkms.2013.28.4.586
This phase II clinical trial was conducted to compare the immunogenicity and safety of a newly developed tetanus-reduced diphtheria (Td) vaccine (GC1107-T5.0 and GC1107-T7.5) and control vaccine. This study was... -
- CITED
-
- Close
- SHARE
-
- Close
